Anterogen Co

Anterogen Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of Anterogen Co (065660.KQ) as of Nov 5, 2026 is -2.22. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was -2.88 — a change of -22.83% (higher).

PEG

-2.22

YoY

-22.83%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Anterogen Co is 2025 -2.22 . PEG Ratio (Price/Earnings-to-Growth) of Anterogen Co was 2024 -2.88 . It decreases by -22.83% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Anterogen Co Stock analysis

What does Anterogen Co do? Anterogen Co., Ltd. generates revenue through the sale of stem cell therapy treatments and related products. The company's product portfolio includes Cupistem, used for treating Crohn’s fistula with autologous adipose-derived mesenchymal stem cells, and stem cell conditioned medias (SCMs), SCM2s, and Therastem-dermas, which serve as cosmetic raw materials to enhance skin function. Remodullins are sold for treating pulmonary arterial hypertension (PAH), while additional products provide testing services. All products are distributed within the domestic market, targeting healthcare providers and cosmetic manufacturers. The company focuses on domestic sales, with no mention of international distribution. Products like Cupistem and Remodullins are medical treatments, while SCMs, SCM2s, and Therastem-dermas cater to the cosmetic industry. The firm's revenue streams are derived from direct sales of these products to domestic customers, including hospitals, clinics, and cosmetic companies seeking advanced therapeutic and cosmetic solutions. Anterogen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Anterogen Co stock

PEG Ratio (Price/Earnings-to-Growth) of Anterogen Co is -2.22 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Anterogen Co changed from -2.88 to -2.22, representing a -22.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Anterogen Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Anterogen Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Anterogen Co

All Key Metrics — Anterogen Co